Significance of High Levels of Endogenous Melatonin in Mammalian Cerebrospinal Fluid and in the Central Nervous System
Journal:
Current Neuropharmacology
Volume:
8
Page:
162-167
Author(s):
Dun-Xian Tan, Lucien C. Manchester, Emilio Sanchez-Barcelo, Maria D. Mediavilla and Russel J. Reiter
Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
Journal:
Current Neuropharmacology
Volume:
8
Page:
211-217
Author(s):
Hongwen He, Weiguo Dong and Fang Huang
Antiinflammatory Activity of Melatonin in Central Nervous System
Journal:
Current Neuropharmacology
Volume:
8
Page:
228-242
Author(s):
Emanuela Esposito and Salvatore Cuzzocrea
Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3015-3027
Author(s):
J. T. Buijs, C. C.H.J. Kuijpers and G. van der Pluijm
A New Twist in Cellular Resistance to the Anticancer Drug Bleomycin-A5
Journal:
Current Drug Metabolism
Volume:
11
Page:
595-602
Author(s):
Mustapha Aouida and Dindial Ramotar
Peptides Targeting Gap Junctional Structures
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3056-3070
Author(s):
Jean-Claude Herve and Stefan Dhein
Bcl-2 Family Proteins as Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3132-3148
Author(s):
Peter E. Czabotar and Guillaume Lessene
STAT3 as a Therapeutic Target for Glioblastoma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
512-519
Author(s):
Yan Liu, Chenglong Li and Jiayuh Lin
Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
520-533
Author(s):
Anthony J. Chalmers
The Potential of Tetrandrine Against Gliomas
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
534-542
Author(s):
Yun Chen and Sheng-Hong Tseng